StonvexLoading…
StonvexStonvexStonvexCore line items from AMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.08M | $28.34M | $21.32M | $19.75M |
Operating Income | $-3.59M | $-2.81M | $270.00K | $2.43M |
Net Income | $-1.55M | $2.19M | $610.00K | $1.33M |
EPS (Diluted) | $-0.23 | $0.33 | $0.10 | $0.21 |
Total Assets | $55.48M | $60.20M | $48.16M | $43.96M |
Total Liabilities | $27.79M | $30.17M | $21.88M | $18.33M |
Cash & Equivalents | $3.46M | $11.03M | $13.69M | $12.34M |
Free Cash Flow OCF − CapEx | $-4.54M | $-7.77M | $-555.00K | $6.85M |
Shares Outstanding | 6.58M | 6.42M | 6.30M | 6.18M |